These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mouse thiopurine methyltransferase pharmacogenetics: correlation of immunoreactive protein and enzymatic activity. Hernandez JS, Van Loon JA, Otterness DM, Weinshilboum RM. J Pharmacol Exp Ther; 1990 Feb; 252(2):568-73. PubMed ID: 2313588 [Abstract] [Full Text] [Related]
4. Thiopurine methyltransferase: mouse kidney and liver assay conditions, biochemical properties and strain variation. Otterness DM, Keith RA, Weinshilboum RM. Biochem Pharmacol; 1985 Nov 01; 34(21):3823-30. PubMed ID: 4062957 [Abstract] [Full Text] [Related]
5. Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isozymes. Szumlanski CL, Honchel R, Scott MC, Weinshilboum RM. Pharmacogenetics; 1992 Aug 01; 2(4):148-59. PubMed ID: 1306116 [Abstract] [Full Text] [Related]
6. Diethyldithiocarbamate S-methylation: evidence for catalysis by human liver thiol methyltransferase and thiopurine methyltransferase. Glauser TA, Nelson AN, Zembower DE, Lipsky JJ, Weinshilboum RM. J Pharmacol Exp Ther; 1993 Jul 01; 266(1):23-32. PubMed ID: 8392551 [Abstract] [Full Text] [Related]
7. Human lymphocyte thiopurine methyltransferase pharmacogenetics: effect of phenotype on 6-mercaptopurine-induced inhibition of mitogen stimulation. Van Loon JA, Weinshilboum RM. J Pharmacol Exp Ther; 1987 Jul 01; 242(1):21-6. PubMed ID: 3612526 [Abstract] [Full Text] [Related]